Sebastien Hazard
Chief Tech/Sci/R&D Officer at IMUNON, INC.
Net worth: 28 800 $ as of 29/04/2024
Sebastien Hazard active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMUNON, INC. | Chief Tech/Sci/R&D Officer | 10/12/2023 | - |
Career history of Sebastien Hazard
Former positions of Sebastien Hazard
| Companies | Position | Start | End |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 31/03/2021 | 31/08/2023 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 31/05/2019 | 31/03/2021 |
| TESARO INC | Chief Tech/Sci/R&D Officer | 31/07/2016 | 30/04/2019 |
Training of Sebastien Hazard
| INSEAD | Masters Business Admin |
Statistics
International
| United States | 3 |
| United Kingdom | 3 |
| France | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| IMUNON, INC. | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 1 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Sebastien Hazard
- Experience
